Saverna Therapeutics
Saverna Therapeutics is a drug discovery company founded in 2017 with a mission to change the way pharmaceutical companies discover and develop safe, orally active small molecules that target non-coding RNA-biology to treat diseases with unmet medical need. They utilize an innovative drug discovery platform combining fragment-based screening, nuclear magnetic resonance spectroscopy, and machine learning to efficiently discover small molecule drugs selectively targeting specific microRNAs (miRNAs). Their goal is to reduce the time and cost in developing small molecule drugs for non-coding RNA targets in inflammation, autoimmune diseases, cancer, and infection. They aim to be the discovery and early-stage development partner of choice for integrated pharmaceutical companies.
Saverna Therapeutics
Saverna Therapeutics is a drug discovery company founded in 2017 with a mission to change the way pharmaceutical companies discover and develop safe, orally active small molecules that target non-coding RNA-biology to treat diseases with unmet medical need. They utilize an innovative drug discovery platform combining fragment-based screening, nuclear magnetic resonance spectroscopy, and machine learning to efficiently discover small molecule drugs selectively targeting specific microRNAs (miRNAs). Their goal is to reduce the time and cost in developing small molecule drugs for non-coding RNA targets in inflammation, autoimmune diseases, cancer, and infection. They aim to be the discovery and early-stage development partner of choice for integrated pharmaceutical companies.